Jakobsen, Gunnhild
Engstrøm, Morten
Paulsen, Ørnulf
Sjue, Karin
Raj, Sunil X.
Thronæs, Morten
Hjermstad, Marianne Jensen
Kaasa, Stein
Fayers, Peter
Klepstad, Pål
Funding for this research was provided by:
Helse Midt-Norge (46083200)
Article History
Received: 19 October 2018
Accepted: 30 November 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: This trial is conducted in accordance with ethical principles that have their origin in the Declaration of Helsinki and are consistent with The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)/Good Clinical Practice and applicable regulatory requirements. We will obtain informed consent from all participants in the trial. Central ethical approval has been confirmed from the Regional Committee for Medical and Health Research Ethics (reference number 2016/353), which is valid for all Norwegian institutions.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.